The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

Abbott, 2009, 11β-Hydroxysteroid Dehydrogenases Are Regulated during the Pulmonary Granulomatous Response to the Mycobacterial Glycolipid Trehalose-6,6’-Dimycolate, Neuroimmunomodulation, 16, 147, 10.1159/000204227

Abraham, 2006, Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1, J. Exp. Med., 203, 1883, 10.1084/jem.20060336

Adams, 2003, Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants, Mol. Endocrinol., 17, 2583, 10.1210/me.2002-0305

Ahmed, 2008, Induction of hepatic 11β-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease, Clin. Endocrinol. (Oxf), 68, 898, 10.1111/j.1365-2265.2007.03125.x

Alam, 1993, Trans-activation of the α1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor, J. Biol. Chem., 268, 15681, 10.1016/S0021-9258(18)82310-9

Arai, 2007, Ceramide and adenosine 5’-monophosphate-activated protein kinase are two novel regulators of 11β-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes, Endocrinology, 148, 5268, 10.1210/en.2007-0349

Ashwell, 2000, Glucocorticoids in T cell development and function, Ann. Rev. Immunol., 18, 309, 10.1146/annurev.immunol.18.1.309

Atanasov, 2008, Direct protein-protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen, Biochim. Biophys. Acta, 1783, 1536, 10.1016/j.bbamcr.2008.03.001

Auphan, 1995, Immunosupression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis, Science, 270, 286, 10.1126/science.270.5234.286

Ayroldi, 2009, Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action, FASEB J., 23, 3649, 10.1096/fj.09-134684

Barish, 2005, A Nuclear Receptor Atlas: macrophage activation, Mol. Endocrinol., 19, 2466, 10.1210/me.2004-0529

Barnes, 1998, Anti-inflammatory actions of glucocorticoids: molecular mechanisms, Clin. Sci. (Lond), 94, 557, 10.1042/cs0940557

Beato, 1989, DNA regulatory elements for steroid hormones, J. Steroid Biochem., 32, 737, 10.1016/0022-4731(89)90521-9

Beato, 1996, Transcriptional regulation by steroid hormones, Steroids, 61, 240, 10.1016/0039-128X(96)00030-X

Berg, 2005, Glucocorticoids increase C/EBPβ activity in the lung epithelium via phosphorylation, Biochem. Biophys. Res. Commun., 334, 638, 10.1016/j.bbrc.2005.06.146

Bertini, 1988, Adrenalectomy sensitizes mice to the lethal effects of Interleukin-1 and Tumor Necrosis Factor, J. Exp. Med., 167, 1708, 10.1084/jem.167.5.1708

Besedovsky, 1996, Immune-neuro-endocrine interactions: facts and hypotheses, Endocr. Rev., 17, 64, 10.1210/edrv-17-1-64

Bhattacharyya, 2007, Macrophage glucocorticoid receptors regulate Toll-like receptor-4-mediated inflammatory responses by selective inhibition of p38 MAP kinase, Blood, 109, 4313, 10.1182/blood-2006-10-048215

Biddie, 2009, Glucocorticoid receptor dynamics and gene regulation, Stress, 12, 193, 10.1080/10253890802506409

Biggadike, 2009, Design and X-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor, Proc. Natl. Acad. Sci. U.S.A., 106, 18114, 10.1073/pnas.0909125106

Blind, 2008, Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes, J. Steroid Biochem. Mol. Biol., 109, 150, 10.1016/j.jsbmb.2008.01.002

Bommhardt, 2004, Molecular and cellular mechanisms of T cell development, Cell. Mol. Life Sci., 61, 263, 10.1007/s00018-003-3224-3

Boyle, 2009, 11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents, Expert Opin. Ther. Pat., 19, 801, 10.1517/13543770902967658

Brewer, 2002, Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo, J. Immunol., 169, 1837, 10.4049/jimmunol.169.4.1837

Brewer, 2003, T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation, Nat. Med., 9, 1318, 10.1038/nm895

Cannarile, 2009, Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis, Gastroenterology, 136, 530, 10.1053/j.gastro.2008.09.024

Cannarile, 2006, Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines, Blood, 107, 1039, 10.1182/blood-2005-05-2183

Chamorro, 2009, TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program, J. Immunol., 183, 2984, 10.4049/jimmunol.0801155

Chapman, 2006, Local amplification of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response, Ann. N.Y. Acad. Sci., 1088, 265, 10.1196/annals.1366.030

Chapman, 2009, The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response, Mol. Cell. Endocrinol., 301, 123, 10.1016/j.mce.2008.09.031

Chapman, 2006, 11β-hydroxysteroid dehydrogenase type 1- a role in inflammation?, Mol. Cell Endocrinol., 248, 3, 10.1016/j.mce.2005.11.036

Cho, 2008, The identification of C/EBPβ as a transcription factor necessary for the induction of MAPK phosphatase-1 by toll-like receptor-4 ligand, Arch. Biochem. Biophys., 479, 88, 10.1016/j.abb.2008.08.007

Clark, 2007, Anti-inflammatory functions of glucocorticoid-induced genes, Mol. Cell. Endocrinol., 275, 79, 10.1016/j.mce.2007.04.013

Clausen, 1999, Conditional gene targeting in macrophages and granulocytes using LysMcre mice, Transgenic Res., 8, 265, 10.1023/A:1008942828960

Cohen, 2006, GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response, Blood, 107, 2037, 10.1182/blood-2005-07-2760

Cole, 1995, Targeted disruption of the glucocorticoid receptor blocks adrenergic chromaffin cell development and severely retards lung maturation, Genes Dev., 9, 1608, 10.1101/gad.9.13.1608

Cole, 2001, GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant, Mol. Cell. Endocrinol., 173, 193, 10.1016/S0303-7207(00)00407-X

Cooper, 2009, 11β-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation, J. Clin. Endocrinol. Metab.

Couper, 2008, IL-10: the master regulator of immunity to infection, J. Immunol., 180, 5771, 10.4049/jimmunol.180.9.5771

Coutinho, 2006, Deficiency in 11β-hydroxysteroid dehydrogenase type 1 results in a more rapid and severe inflammation, 2

Croniger, 1997, Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth, J. Biol. Chem., 272, 26306, 10.1074/jbc.272.42.26306

Croxtall, 2002, Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells, Br. J. Pharmacol., 135, 511, 10.1038/sj.bjp.0704474

D’Acquisto, 2007, Annexin-1 modulates T-cell activation and differentiation, Blood, 109, 1095, 10.1182/blood-2006-05-022798

D’Acquisto, 2008, Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells, Rheumatology (Oxford), 47, 636, 10.1093/rheumatology/ken062

D’Acquisto, 2007, Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells, Eur. J. Immunol., 37, 3131, 10.1002/eji.200636792

D’Elia, 2009, Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice, Am. J. Physiol. Endocrinol. Metab., 296, E97, 10.1152/ajpendo.90582.2008

De Bosscher, 2009, Latest perspectives on anti-inflammatory actions of glucocorticoids, Mol. Endocrinol., 23, 281, 10.1210/me.2008-0283

de Vries, 2007, Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study, J. Intern. Med., 261, 170, 10.1111/j.1365-2796.2006.01754.x

Delfino, 2006, Inhibited cell death, NF-|B activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ, Int. Immunopharmacol., 6, 1126, 10.1016/j.intimp.2006.02.001

Du, 2009, Insulin Regulates TRB3 and Other Stress Responsive Gene Expression through Induction of C/EBPβ, Mol. Endocrinol., 23, 475, 10.1210/me.2008-0284

Ehrchen, 2007, Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes, Blood, 109, 1265, 10.1182/blood-2006-02-001115

Elmore, 2004, Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators, Bioorg. Med. Chem. Lett., 14, 1721, 10.1016/j.bmcl.2004.01.044

Ergang, 2007, Glucocorticoid availability in colonic inflammation of rat, Dig. Dis. Sci., 53, 2160, 10.1007/s10620-007-0125-6

Fadok, 1998, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-βPGE2, and PAF, J. Clin. Invest., 101, 890, 10.1172/JCI1112

Finotto, 1999, Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells, Development, 126, 2935, 10.1242/dev.126.13.2935

Fiore, 2009, Identification of the 11β-hydroxysteroid dehydrogenase type 1 mRNA and protein in human mononuclear leukocytes, Exp. Clin. Endocrinol. Diabetes, 117, 514, 10.1055/s-0028-1105924

Frank, 2010, Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide, Brain Behav. Immun., 24, 19, 10.1016/j.bbi.2009.07.008

Freeman, 2005, Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells, Blood, 106, 2042, 10.1182/blood-2005-01-0186

Funder, 1997, Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance, Annu. Rev. Med., 48, 231, 10.1146/annurev.med.48.1.231

Giles, 2001, Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac, J. Immunol., 167, 976, 10.4049/jimmunol.167.2.976

Gilmour, 2006, Local amplification of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes, J. Immunol., 176, 7605, 10.4049/jimmunol.176.12.7605

Gilroy, 2004, The endogenous control of acute inflammation - from onset to resolution, Drug Discov. Today: Therap. Strategies, 1, 313

Godfrey, 2001, Glucocorticoids and the thymus: the view from the middle of the road, Trends Immunol., 22, 243, 10.1016/S1471-4906(01)01916-0

Gotoh, 1997, The glucocorticoid-responsive gene cascade: activation of the rat arginase gene through induction of C/EBPβ, J. Biol. Chem., 272, 3694, 10.1074/jbc.272.6.3694

Goulding, 1990, Hydrocortisone induces lipocortin 1 production by peripheral blood mononuclear cells in vivo in man, Biochem. Soc. Trans., 18, 306, 10.1042/bst0180306

Gout, 2006, CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11β-hydroxysteroid dehydrogenase encoding gene in adipose cells, Biochimie, 88, 1115, 10.1016/j.biochi.2006.05.020

Grange, 2001, In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action, Oncogene, 20, 3028, 10.1038/sj.onc.1204327

Grange, 1989, Two remote glucocorticoid responsive units interact cooperatively to promote glucocorticoid induction of rat tyrosine aminotransferase gene expression, Nucl. Acids Res., 17, 8695, 10.1093/nar/17.21.8695

Grange, 1991, Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP and a novel liver-specific nuclear factor, Nucl. Acids Res., 19, 131, 10.1093/nar/19.1.131

Haas, 2006, Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins, Arthritis Rheum., 54, 2047, 10.1002/art.21953

Hager, 2004, Dynamics of nuclear receptor movement and transcription, Biochim. Biophys. Acta, 1677, 46, 10.1016/j.bbaexp.2003.09.016

Hamdi, 2007, Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper, Blood, 110, 211, 10.1182/blood-2006-10-052506

Hammer, 2006, Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock, J. Exp. Med., 203, 15, 10.1084/jem.20051753

Hannon, 2003, Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse, FASEB J., 17, 253, 10.1096/fj.02-0239fje

Härd, 1990, Solution structure of the glucocorticoid receptor DNA-binding domain, Science, 249, 157, 10.1126/science.2115209

Hardy, 2008, Local and systemic glucocorticoid metabolism in inflammatory arthritis, Ann. Rheum. Dis., 67, 1204, 10.1136/ard.2008.090662

Harizi, 2008, Inter-strain differences in glucocorticoid and mineralocorticoid effects on macrophage and lymphocyte functions in mice, J. Neuroimmunol., 204, 38, 10.1016/j.jneuroim.2008.08.004

Haslett, 1991, Apoptosis (programmed cell death) and functional changes in aging neutrophils: modulation by inflammatory mediators, Chest, 99, 6S, 10.1378/chest.99.3_Supplement.6S

Hawes, 1995, Chronic pathophysiologic elevation of corticosterone after thermal injury or thermal injury and burn wound infection adversely affects body mass, lymphocyte numbers, and outcome, J. Burn Care Rehabil., 16, 1, 10.1097/00004630-199501000-00002

Hawrylowicz, 2005, Regulatory T cells and IL-10 in allergic inflammation, J. Exp. Med., 202, 1459, 10.1084/jem.20052211

Heasman, 2003, Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation, J. Endocrinol., 178, 29, 10.1677/joe.0.1780029

Heck, 1997, IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor, EMBO J., 16, 4698, 10.1093/emboj/16.15.4698

Heck, 1994, A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1, EMBO J., 13, 4087, 10.1002/j.1460-2075.1994.tb06726.x

Hennebold, 1996, 11β-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs, Am. J. Physiol., 270, R1296

Hermanowski-Vosatka, 2005, 11®-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice, J. Exp. Med., 202, 517, 10.1084/jem.20050119

Herold, 2006, Glucocorticoids in T cell apoptosis and function, Cell. Mol. Life Sci., 63, 60, 10.1007/s00018-005-5390-y

Hollenberg, 1985, Primary structure and expression of a functional human glucocorticoid receptor cDNA, Nature, 318, 635, 10.1038/318635a0

Horie-Inoue, 2006, Identification of novel steroid target genes through the combination of bioinformatics and functional analysis of hormone response elements, Biochem. Biophys. Res. Commun., 339, 99, 10.1016/j.bbrc.2005.10.188

Hu, 2007, An essential role for CCAAT/enhancer binding protein β in bleomycin-induced pulmonary fibrosis, J. Pathol., 211, 455, 10.1002/path.2119

Huggins, 2009, Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation, Faseb J., 23, 985, 10.1096/fj.08-119040

Ignatova, 2009, Tumor necrosis factor-〈 upregulates 11β-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-β in HepG2 cells, Am. J. Physiol. Endocrinol. Metab., 296, E367, 10.1152/ajpendo.90531.2008

Imai, 1990, Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene, Mol. Cell. Biol., 10, 4712, 10.1128/MCB.10.9.4712

Ito, 2009, Foxo1 increases pro-inflammatory gene expression by inducing C/EBPβ in TNFα-treated adipocytes, Biochem. Biophys. Res. Commun., 378, 290, 10.1016/j.bbrc.2008.11.043

Jaffe, 1924, The influence of the suprarenal gland on the thymus, J. Exp. Med., XL, 325, 10.1084/jem.40.3.325

Jang, 2009, Skeletal muscle 11β-hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery, Eur. J. Endocrinol., 160, 249, 10.1530/EJE-08-0619

Johansson Haque, 2008, Stimulation of MAPK-phospatase 1 (MKP-1) gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP, J. Mol. Endocrinol., 41, 239, 10.1677/JME-08-0015

John, 2009, Kinetic complexity of the global response to glucocorticoid receptor action, Endocrinology, 150, 1766, 10.1210/en.2008-0863

John, 2008, Interaction of the glucocorticoid receptor with the chromatin landscape, Mol. Cell., 29, 611, 10.1016/j.molcel.2008.02.010

Jonat, 1990, Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos Jun) activity by glucocorticoid hormone, Cell, 62, 1189, 10.1016/0092-8674(90)90395-U

Jondal, 2004, Different roles for glucocorticoids in thymocyte homeostasis?, Trends Immunol., 25, 595, 10.1016/j.it.2004.09.003

Kardon, 2008, Maintenance of luminal NADPH in the endoplasmic reticulum promotes the survival of human neutrophil granulocytes, FEBS Lett., 582, 1809, 10.1016/j.febslet.2008.04.045

Karin, 1998, New twists in gene regulation by glucocorticoid receptor: Is DNA binding dispensable?, Cell, 93, 487, 10.1016/S0092-8674(00)81177-0

Kassel, 2002, Mast cells as targets for glucocorticoids in the treatment of allergic disorders, Ernst Schering Res. Found Workshop, 153

Kimura, 2001, CCAAT/enhancer-binding protein β is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary- cultured hepatocytes, FEBS Lett., 494, 105, 10.1016/S0014-5793(01)02320-1

King, 1995, A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development, Immunity, 3, 647, 10.1016/1074-7613(95)90135-3

Kizaki, 1998, An increase in basal glucocorticoid concentration with age induces suppressor macrophages with high-density Fc gamma RII/III, Immunology, 93, 409, 10.1046/j.1365-2567.1998.00433.x

Kleiman, 2007, Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice, Mol. Cell. Endocrinol., 275, 98, 10.1016/j.mce.2007.05.009

Koldzic-Zivanovic, 2006, Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata, Brain Behav. Immun., 20, 460, 10.1016/j.bbi.2005.09.003

Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P

Lacy-Hulbert, 2007, Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins, Proc. Natl. Acad. Sci. U.S.A., 104, 15823, 10.1073/pnas.0707421104

Lefstin, 1998, Allosteric effects of DNA on transcriptional regulators, Nature, 392, 885, 10.1038/31860

Lightman, 2008, The neuroendocrinology of stress: a never ending story, J. Neuroendocrinol., 20, 880, 10.1111/j.1365-2826.2008.01711.x

Lim, 2007, Glucocorticoids exert opposing effects on macrophage function dependent on their concentration, Immunology, 122, 47, 10.1111/j.1365-2567.2007.02611.x

Limbourg, 2002, Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids, J. Clin. Invest., 110, 1729, 10.1172/JCI0215481

Lu, 2000, Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to “holes” in the T cell repertoire, Immunity, 12, 183, 10.1016/S1074-7613(00)80171-5

Luisi, 1991, Crystallographic analysis of the interaction of the glucocorticoid receptor With DNA, Nature, 352, 497, 10.1038/352497a0

Luther, 2009, Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients, J. Immunol., 183, 841, 10.4049/jimmunol.0802046

Madauss, 2008, The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist, Bioorg. Med. Chem. Lett., 18, 6097, 10.1016/j.bmcl.2008.10.021

Maderna, 2005, Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26), J. Immunol., 174, 3727, 10.4049/jimmunol.174.6.3727

Maier, 2007, Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids, Mol. Endocrinol., 21, 2663, 10.1210/me.2007-0067

Martinez, 2006, Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression, J. Immunol., 177, 7303, 10.4049/jimmunol.177.10.7303

McColl, 2009, Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages, J. Immunol., 183, 2167, 10.4049/jimmunol.0803503

McColl, 2007, Effects of glucocorticoids on apoptosis and clearance of apoptotic cells, Sci. W. J., 7, 1165, 10.1100/tsw.2007.224

McEwen, 1997, The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions, Brain Res. Rev., 23, 79, 10.1016/S0165-0173(96)00012-4

McKay, 1999, Molecular control of immune/inflammatory responses: Interactions between NF-κB and steroid receptor-signaling pathways, Endocrinol. Rev., 20, 435

McKnight, 2001, McBindall—a better name for CCAAT/enhancer binding proteins?, Cell, 107, 259, 10.1016/S0092-8674(01)00543-8

Meijsing, 2009, DNA binding site sequence directs glucocorticoid receptor structure and activity, Science, 324, 407, 10.1126/science.1164265

Miesfeld, 1986, Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA, Cell, 46, 389, 10.1016/0092-8674(86)90659-8

Miller, 1990, Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone, Am. J. Physiol., 259, E405

Millward, 2007, Mice with a deletion in the gene for CCAAT/enhancer-binding protein β are protected against diet-induced obesity, Diabetes, 56, 161, 10.2337/db06-0310

Mozo, 2004, Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes, Clin. Exp. Allergy, 34, 406, 10.1111/j.1365-2222.2004.01824.x

Munck, 1984, Physiological functions of glucocorticoids in stress and their relationship to pharmacological actions, Endocrinol. Rev., 5, 25, 10.1210/edrv-5-1-25

Muzikar, 2009, Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression, Proc. Natl. Acad. Sci. U.S.A., 106, 16598, 10.1073/pnas.0909192106

Necela, 2004, Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells, Proc. Am. Thorac. Soc., 1, 239, 10.1513/pats.200402-005MS

Nerlov, 2007, The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control, Trends Cell Biol., 17, 318, 10.1016/j.tcb.2007.07.004

Newton, 2007, Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?, Mol. Pharmacol., 72, 799, 10.1124/mol.107.038794

O'Sullivan, 2002, CD40 Ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-κB, J. Immunol., 168, 5491, 10.4049/jimmunol.168.11.5491

Olsen, 2004, A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells, Ann. Rheum. Dis., 63, 1387, 10.1136/ard.2003.017194

Payne, 2007, Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPβ) and C/EBPα during adipogenesis, J. Biol. Chem., 282, 21005, 10.1074/jbc.M702871200

Payvar, 1983, Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region, Cell, 35, 381, 10.1016/0092-8674(83)90171-X

Pazirandeh, 2005, Conditional expression of a glucocorticoid receptor transgene in thymocytes reveals a role for thymic-derived glucocorticoids in thymopoiesis in vivo, Endocrinology, 146, 2501, 10.1210/en.2004-0943

Pazirandeh, 2002, Effects of altered glucocorticoid sensitivity in the T-cell lineage on thymocyte and T-cell homeostasis, FASEB J., 16, 727, 10.1096/fj.01-0891fje

Pearce, 1993, Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element, Science, 259, 1161, 10.1126/science.8382376

Penner, 2002, C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle, Am. J. Physiol. Regul. Integr. Comp. Physiol., 282, R439, 10.1152/ajpregu.00512.2001

Pepin, 1992, Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene, Nature, 355, 725, 10.1038/355725a0

Perretti, 2000, The microcirculation and inflammation: site of action for glucocorticoids, Microcirculation, 7, 147, 10.1111/j.1549-8719.2000.tb00117.x

Perretti, 2009, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation, Nat. Rev. Immunol., 9, 62, 10.1038/nri2470

Planey, 2000, Glucocorticoid-induced apoptosis in lymphocytes, Biochem. Biophys. Res. Commun., 279, 307, 10.1006/bbrc.2000.3922

Purton, 2000, Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling, Immunity, 13, 179, 10.1016/S1074-7613(00)00018-2

Purton, 2004, Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death, J. Immunol., 173, 3816, 10.4049/jimmunol.173.6.3816

Purton, 2002, Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice, Eur. J. Immunol., 32, 3546, 10.1002/1521-4141(200212)32:12<3546::AID-IMMU3546>3.0.CO;2-S

Rea, 2000, Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10, Blood, 95, 3162, 10.1182/blood.V95.10.3162

Reddy, 2009, Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation, Genome Res., 19, 2163, 10.1101/gr.097022.109

Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6

Reichardt, 2001, Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor, EMBO J., 20, 7168, 10.1093/emboj/20.24.7168

Reichardt, 2000, Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock, Mol. Cell. Biol., 20, 9009, 10.1128/MCB.20.23.9009-9017.2000

Rennick, 1995, Interleukin-10 gene knock-out mice: a model of chronic inflammation, Clin. Immunol. Immunopathol., 76, S174, 10.1016/S0090-1229(95)90144-2

Rhen, 2005, Antiinflammatory action of glucocorticoids - new mechanisms for old drugs, N. Engl. J. Med., 353, 1711, 10.1056/NEJMra050541

Richards, 2000, Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4 IL-5 and IL-13 production, Eur. J. Immunol., 30, 2344, 10.1002/1521-4141(2000)30:8<2344::AID-IMMU2344>3.0.CO;2-7

Rogatsky, 2003, Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor, Proc. Natl. Acad. Sci. U.S.A., 100, 13845, 10.1073/pnas.2336092100

Rook, 1994, Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance, Immunol. Today, 15, 301, 10.1016/0167-5699(94)90075-2

Rosenstock, 2009

Ruffell, 2009, A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair, Proc. Natl. Acad. Sci. U.S.A., 106, 17475, 10.1073/pnas.0908641106

Rutella, 2004, Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications, Immunol. Lett., 94, 11, 10.1016/j.imlet.2004.04.015

Sai, 2008, Glucocorticoid regulation of the promoter of 11β-hydroxysteroid dehydrogenase type 1 is indirect and requires C/EBPβ, Mol. Endocrinol., 22, 2049, 10.1210/me.2007-0489

Sai, 2009, Differential regulation of 11β-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia, Leuk. Res., 33, 1696, 10.1016/j.leukres.2009.04.016

Salojin, 2006, Essential role of MAPK phosphatase-1 in the negative control of innate immune responses, J. Immunol., 176, 1899, 10.4049/jimmunol.176.3.1899

Savill, 2002, A blast from the past: clearance of apoptotic cells regulates immune responses, Nat. Rev. Immunol., 2, 965, 10.1038/nri957

Savoldi, 1997, The glucocorticoid receptor regulates the binding of C/EBPβ on the α1-acid glycoprotein promoter in vivo, DNA Cell Biol., 16, 1467, 10.1089/dna.1997.16.1467

Schacke, 2007, Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index, Mol. Cell. Endocrinol., 275, 109, 10.1016/j.mce.2007.05.014

Scheinman, 1995, Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids, Science, 270, 283, 10.1126/science.270.5234.283

Schmidt, 2005, Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: Possible role of the sympathetic nervous system?, Arthritis Rheum., 52, 1711, 10.1002/art.21091

Schroeder-Gloeckler, 2007, CCAAT/enhancer-binding protein-β deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice, J. Biol. Chem., 282, 15717, 10.1074/jbc.M701329200

Seckl, 2000, 11β-hydroxysteroid dehydrogenases, Encyclopedia Stress, 2, 413

Seckl, 2004, Glucocorticoids and 11β-hydroxysteroid dehydrogenase in adipose tissue, Recent Prog. Horm. Res., 59, 359, 10.1210/rp.59.1.359

Serhan, 2005, Resolution of inflammation: the beginning programs the end, Nat. Immunol., 6, 1191, 10.1038/ni1276

Shanks, 2000, Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation, Proc. Natl. Acad. Sci. U.S.A., 97, 5645, 10.1073/pnas.090571897

Sica, 2007, Altered macrophage differentiation and immune dysfunction in tumor development, J. Clin. Invest., 117, 1155, 10.1172/JCI31422

Simons, 2008, What goes on behind closed doors: physiological versus pharmacological steroid hormone actions, Bioessays, 30, 744, 10.1002/bies.20792

Smoak, 2004, Mechanisms of glucocorticoid receptor signaling during inflammation, Mech. Ageing Dev., 125, 697, 10.1016/j.mad.2004.06.010

So, 2007, Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor, PLoS Genet., 3, e94, 10.1371/journal.pgen.0030094

So, 2008, Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes, Proc. Natl. Acad. Sci. U.S.A., 105, 5745, 10.1073/pnas.0801551105

Solito, 2003, Endocrinology, 144, 1164, 10.1210/en.2002-220592

Sorrells, 2009, The stressed CNS: when glucocorticoids aggravate inflammation, Neuron, 64, 33, 10.1016/j.neuron.2009.09.032

Souverein, 2004, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, 90, 859, 10.1136/hrt.2003.020180

Staiger, 2008, C/EBPβ regulates body composition, energy balance-related hormones, and tumor growth, Carcinogenesis, 30, 832, 10.1093/carcin/bgn273

Stavreva, 2009, Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription, Nat. Cell Biol., 11, 1093, 10.1038/ncb1922

Stellato, 2004, Post-transcriptional and nongenomic effects of glucocorticoids, Proc. Am. Thorac. Soc., 1, 255, 10.1513/pats.200402-015MS

Sternberg, 2006, Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens, Nat. Rev. Immunol., 6, 318, 10.1038/nri1810

Tchen, 2009, Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence, J. Biol. Chem.

Thieringer, 2001, 11β-Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages, J. Immunol., 167, 30, 10.4049/jimmunol.167.1.30

Tuckermann, 2005, Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis, Crit. Rev. Clin. Lab Sci., 42, 71, 10.1080/10408360590888983

Tuckermann, 2007, Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy, J. Clin. Invest., 117, 1381, 10.1172/JCI28034

Umesono, 1989, Determinants of target gene specificity for steroid/thyroid hormone receptors, Cell, 57, 1139, 10.1016/0092-8674(89)90051-2

van der Laan, 2008, Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain, J. Neurochem., 106, 2515, 10.1111/j.1471-4159.2008.05575.x

van Staa, 2000, Use of oral corticosteroids in the United Kingdom, QJM, 93, 105, 10.1093/qjmed/93.2.105

van Tilborg, 2000, Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA, J. Mol. Biol., 301, 947, 10.1006/jmbi.2000.4001

Varga, 2008, Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells, J. Leukoc. Biol., 84, 644, 10.1189/jlb.1107768

Vegiopoulos, 2007, Glucocorticoids, metabolism and metabolic diseases, Mol. Cell Endocrinol., 275, 43, 10.1016/j.mce.2007.05.015

Wang, 2006, Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells, J. Immunol., 176, 1695, 10.4049/jimmunol.176.3.1695

Wang, 2004, Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes, Proc. Natl. Acad. Sci. U.S.A., 101, 15603, 10.1073/pnas.0407008101

Webster, 2002, Neuroendocrine regulation of immunity, Annu. Rev. Immunol., 20, 125, 10.1146/annurev.immunol.20.082401.104914

Wei, 2004, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease, Ann. Intern. Med., 141, 764, 10.7326/0003-4819-141-10-200411160-00007

White, 2007, Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism, Mol. Cell. Endocrinol., 265-266, 89, 10.1016/j.mce.2006.12.022

Whorwood, 1992, Tissue localisation of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor, J. Steroid Biochem. Mol. Biol., 41, 21, 10.1016/0960-0760(92)90220-D

Whyte, 1993, Impairment of function in aging neutrophils is associated with apoptosis, J. Immunol., 150, 5124, 10.4049/jimmunol.150.11.5124

Wilckens, 1995, Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction, Trends Pharmacol. Sci., 16, 193, 10.1016/S0165-6147(00)89021-5

Wilckens, 1997, Glucocorticoids and immune function: unknown dimensions and new frontiers, Immunol. Today, 18, 418, 10.1016/S0167-5699(97)01111-0

Williams, 2000, C/EBP regulates hepatic transcription of 11β-hydroxysteroid dehydrogenase type 1; a novel mechanism for cross talk between the C/EBP and glucocorticoid signalling pathways, J. Biol. Chem., 275, 30232, 10.1074/jbc.M001286200

Wissink, 1998, A dual mechanism mediates repression of NF-κB activity by glucocorticoids, Mol. Endocrinol., 12, 355

Wu, 2006, Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity, Cell Metab., 4, 61, 10.1016/j.cmet.2006.05.010

Wust, 2008, Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis, J. Immunol., 180, 8434, 10.4049/jimmunol.180.12.8434

Yamada, 1999, CCAAT/enhancer-binding protein β is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter, J. Biol. Chem., 274, 5880, 10.1074/jbc.274.9.5880

Yamamoto, 1985, Steroid receptor regulated transcription of specific genes and gene networks, Ann. Rev. Genet., 19, 209, 10.1146/annurev.ge.19.120185.001233

Yang, 2005, Expression and activity of C/EBPβ and δ are upregulated by dexamethasone in skeletal muscle, J. Cell. Physiol., 204, 219, 10.1002/jcp.20278

Yang, 2005, Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPβ in cultured myotubes, J. Cell. Biochem., 94, 1058, 10.1002/jcb.20371

Yang, 2009, Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper, J. Immunol., 183, 1435, 10.4049/jimmunol.0804000

Yang, 2004, Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis, Arthritis Rheum., 50, 976, 10.1002/art.20201

Yang, 2007, Role of glucocorticoid receptor and CCAAT/enhancer-binding protein-α in the feed-forward induction of 11β-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts, J. Endocrinol., 195, 241, 10.1677/JOE-07-0303

Yang, 2009, Stimulation of 11β-HSD1 expression by IL-1β via a C/EBP binding site in human fetal lung fibroblasts, Endocrine, 36, 404, 10.1007/s12020-009-9245-4

Yangyen, 1990, Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction, Cell, 62, 1205, 10.1016/0092-8674(90)90396-V

Yeager, 2004, Glucocorticoid regulation of the inflammatory response to injury, Acta Anaesthesiol. Scand., 48, 799, 10.1111/j.1399-6576.2004.00434.x

Yona, 2004, Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages, Br. J. Pharmacol., 142, 890, 10.1038/sj.bjp.0705858

Yoshinaga, 1991, Signaling and regulation by a mammalian glucocorticoid receptor in Drosophila cells, Mol. Endocrinol., 5, 844, 10.1210/mend-5-6-844

Zbankova, 2007, 11β-hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis, J. Gastroenterol. Hepatol., 22, 1019, 10.1111/j.1440-1746.2006.04529.x

Zhang, 2009, Characterization of a novel gain of function glucocorticoid receptor knock-in mouse, J. Biol. Chem., 284, 6249, 10.1074/jbc.M807997200

Zhang, 2007, Macrophages from 11β-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-β-mediated up-regulation of SHIP1 expression, J. Immunol., 179, 6325, 10.4049/jimmunol.179.9.6325

Zhang, 2005, The expression of 11β-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities, J. Immunol., 174, 879, 10.4049/jimmunol.174.2.879

Zhao, 2006, MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock, J. Exp. Med., 203, 131, 10.1084/jem.20051794